%PDF-1.3 % 2 0 obj <> endobj 4 0 obj <>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream xs w3T04PI2P0T5T0P02S04S  @$P5 )1 endstream endobj 3 0 obj <>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream xs w3T04PI2P0T5TR Ɩf !\!Y\ !p)P endstream endobj 8 0 obj <>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream xs w3T04PI2P0T5T0q-Br44C@B 9 s (P endstream endobj 9 0 obj <>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream xs w3T04PI2P0T5TR Ɩf !\!Y\ !p)P endstream endobj 5 0 obj <>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream xs w3T04PI2P0T5T0q-Br44C@B 9 s (P endstream endobj 7 0 obj <>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream xs w3T04PI2P0T5T0P02S04S  @$P5 )1 endstream endobj 1 0 obj <>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream xs w3T04PI2P0T5T0q-Br44C@B 9 s (P endstream endobj 10 0 obj <>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream xs w3T04PI2P0T5T0P02S04S  @$P5 )1 endstream endobj 6 0 obj <>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream xs w3T04PI2P0T5TR Ɩf !\!Y\ !p)P endstream endobj 11 0 obj <>stream 2013-03-19T18:33:42+05:30 Arbortext Advanced Print Publisher 9.0.114/W 2013-05-24T03:32:53-07:00 Acrobat Distiller 8.1.0 (Windows) application/pdf untitled uuid:648932f2-5226-4e00-bb27-4526ae1187c5 uuid:a8d15456-bc36-41e3-bfd2-979aff8eea20 endstream endobj 12 0 obj <>stream x+| endstream endobj 13 0 obj <>stream xS**T0T0BiU)D* 9V endstream endobj 14 0 obj <>stream x+| endstream endobj 15 0 obj <>stream xS**T0T0BiUD* 8 endstream endobj 16 0 obj <>stream x+| endstream endobj 17 0 obj <>stream xS**T0T0BiUD* : endstream endobj 18 0 obj <>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 24 0 R/MediaBox[0 0 612 792]/Rotate 0>> endobj 25 0 obj <>/ProcSet[/PDF/Text]/Font<>>> endobj 20 0 obj <>stream /GS1 gs BT /F4 1 Tf 8.9663 0 0 8.9663 69.7323 725.7825 Tm 0 0 0 1 k 0 Tc 0 Tw [(This)-422.2(inconsistency)-430.6(of)-420.6(published)-426.5(maps)-417.1(presents)-425.6(a)-423.1(serious)]TJ -1.1128 -1.2203 TD [(methodological)-393.2(research)-384.1(challenge)-389.9(if)-383.4(the)-383.1(intention)-387.6(is)-384.2(to)-388.9(iso-)]TJ 0 -1.2266 TD [(late)-578.8(a)-581.2(specic)-576.7(treatment-related)-585.2(hemodynamic)-583.4(effect)-582.2(and)]TJ 0 -1.2203 TD [(create)-366.5(a)-353.6(reproducible)-368.2(reexology)-358.7(intervention.)-366.5(The)-360.4(majority)]TJ T* [(of)-584.9(existing)-581.4(reexology)-580(studies)-579.9(do)-581.2(not)-582(provide)-581.1(details)-580.3(of)]TJ 0 -1.2266 TD [(which)-491.8(reexology)-491.5(map)-491.6(the)-490.6(intervention)-496.4(is)-491.7(founded)-488.1(upon,)]TJ 0 -1.2203 TD [(which)-384.3(means)-387.4(that)-383.2(some)-380.9(of)-382.6(the)-383.1(studies)-390.3(are,)-382.4(in)-380(theory,)-387.6(using)]TJ T* [(different)-290(reexology)-282.8(points)-284.7(on)-278(which)-283.1(to)-287.8(base)-277(the)-282(supposedly)]TJ 0 -1.2266 TD [(same)-251.2(intervention.)-259(Clearly,)-248.6(if)-250.6(this)-255.3(is)-251.4(the)-250.3(case,)-249.5(there)-250.9(is)-251.4(a)-252.4(lack)-247(of)]TJ 0 -1.2203 TD [(consistency)-524.9(in)-512.8(the)-515.9(intervention)-521.7(approach,)-523(which)-517(arguably)]TJ T* [(invalidates)-340.9(the)-332.5(validity)-334.9(and)-334.7(generalizability)-337.3(of)-332(any)-329.8(ndings,)]TJ T* [(whether)-338.2(positive)-336.1(or)-338.6(negative.)]TJ /F3 1 Tf 0 -2.447 TD [(Poor)-338.7(Experimental)-334.2(Controls)]TJ /F4 1 Tf 1.1128 -1.8336 TD [(Aside)-571.9(from)-570.6(the)-572.8(map)-567.5(inconsistencies,)-579.3(many)-567.6(reexology)]TJ -1.1128 -1.2203 TD [(studies)-346(present)-342.1()55(sham)51.4()-337(reexology)-339.7(in)-342(the)-338.9(form)-336.6(of)-344.7(foot)-341.6(mas-)]TJ 0 -1.2266 TD [(sage)-359.2(as)-354.9(the)-357.8(placebo)-358.5(or)-351.2(experimental)-359.7(control,)-357.3(yet)-358.9(provide)-359.8(no)]TJ 0 -1.2203 TD [(clear)-394.9(description)-392.3(of)-388.9(how)-387.2(the)-389.5(foot)-392.2(massage)-389.2(treatment)-394.4(is)-390.5(dis-)]TJ T* [(tinguishable)-420.8(from)-418.8(general)-422.3(foot)-417.5(massage.)]TJ 6.7246 0 0 5.9768 222.2362 527.0172 Tm (1)Tj 8.9663 0 0 8.9663 229.3228 523.0487 Tm [(This)-415.9(is)-415.8(a)-416.8(particu-)]TJ -18.9118 -1.2266 TD [(larly)-277.3(important)-281.7(distinction)-283.9(to)-275.1(consider)-279.5(within)-281.5(the)-275.6(reexology)]TJ 0 -1.2203 TD [(theoretical)-266.4(construct)-255.6(because)-264.9(foot)-253.1(massage)-262.8(of)-256.2(the)-256.7(plantar)-255.1(foot)]TJ T* [(area)-537.1(may)-532.6(also)-538.3(unintentionally)-542.4()55(treat)52.1()-533(organ)-535.6(reex)-536.8(points)]TJ T* [(during)-389.4(the)-383.1(control)-386(treatment.)-391(Therefore,)-386.7(it)-389.7(is)-384.2(clear)-382.3(that)-383.2(foot)]TJ 0 -1.2266 TD [(massage)-559.9(does)-563.4(not)-563(provide)-562.1(a)-555.9(suitably)-562.3(ineffectual)-568.2(form)-557.9(of)]TJ 0 -1.2203 TD [(control)-341.7(in)-329.4(reexology)-339.7(research.)]TJ 1.1128 -1.2203 TD [(Furthermore,)-394.2(the)-395.8(majority)-393.3(of)-395.3(studies)-390.3(deliver)-397(the)-389.5(reexol-)]TJ -1.1128 -1.2266 TD [(ogy)-479.5(intervention)-483.8(as)-475(a)-480.1()55(whole)-474.7(system)50()-476.1(complex)-480.8(treatment,)]TJ 0 -1.2203 TD [(making)-303.7(no)-297(attempt)-303.2(to)-300.4(control)-303.8(for)-301.1(nonspecic)-308.1(effects)-299(in)-304.1(order)]TJ T* [(to)-591.3(isolate)-592.7(any)-589(active)-585.1(specic)-595.7(effect.)-591.4(Within)-588.7(this)-590.4(research)]TJ 0 -1.2266 TD [(framework,)-465.8(model)-468.3(validity)-461.3(is)-466.4(more)-468.8(of)-464.8(a)-461.1(priority)-466.4(and)-461.2(con-)]TJ 0 -1.2203 TD [(ceptually,)-534.8(many)-529.7(aspects)-534.3(of)-534.4(a)-530.6(therapeutic)-534.7(intervention)-540.7(are)]TJ T* [(regarded)-447.4(as)-443.4(inherently)-452.6(culture-specic.)]TJ 6.7246 0 0 5.9768 217.474 384.5479 Tm (13,14)Tj 8.9663 0 0 8.9663 236.6361 380.5794 Tm [(This)-447.5(interpreta-)]TJ -19.7275 -1.2203 TD [(tion)-395.9(means)-387.4(that)-395.9(the)-389.5(researchers)-392.3(do)-391.5(not)-392.3(attempt)-391.8(to)-395.3(translate)]TJ 0 -1.2266 TD [(the)-357.8(context)-356.2(of)-357.3(the)-357.8(therapy)-351.2(into)-357.9(the)-357.8(experimental)-359.7(framework)]TJ 0 -1.2203 TD [(of)-622.9(the)-617.1(randomized)-619.9(controlled)-620(study)-617.6(design,)-619.2(in)-613.9(order)-620.4(to)]TJ T* [(eliminate)-656.3(any)-652.3(nonspecic)-655.8(components,)-660.1(such)-656.6(as)-652.1(placebo,)]TJ 0 -1.2266 TD [(therapeutic)-477.8(or)-477.7(environmental)-474(effects.)]TJ 6.7246 0 0 5.9768 209.5369 329.7826 Tm (15)Tj 8.9663 0 0 8.9663 220.5354 325.7574 Tm [(However,)-470.1(although)]TJ -17.9318 -1.2203 TD [(the)-591.8(whole)-586.6(systems)-594.3(framework)-589.4(allows)-587.7(for)-585.6(more)-589(sensitive)]TJ T* [(evaluation)-274(of)-268.8(complex)-272.1(health)-275.7(care)-265(interventions,)]TJ 6.7246 0 0 5.9768 248.7117 307.8424 Tm (14)Tj 8.9663 0 0 8.9663 257.8393 303.8739 Tm [(in)-266.2(the)-275.6(case)]TJ -22.0923 -1.2266 TD [(of)-458.5(the)-452.7(specic)-456.6(claims)-453.7(of)-458.5(reexology,)-456.4(there)-453.3(are)-455.4(ethical)-452.2(con-)]TJ 0 -1.2203 TD [(siderations)-373.5(that)-376.9(need)-366.6(to)-370(be)-371(addressed)-372(if)-370.7(the)-370.5(value)-371.8(of)-370(reex-)]TJ T* [(ology)-289.8(relies)-287.1(predominantly)-289.1(on)-284.4(placebo)-289(or)-288(nonspecic)-289.1(effects.)]TJ 0 -1.2267 TD [(The)-436.2(key)-438.7(issue)-437.4(here)-433.8(being)-433(whether)-439.3(researchers)-442.9(can)-432.1(provide)]TJ 0 -1.2203 TD [(evidence)-306.8(for)-301.1(the)-307.3(specic)-304.8(hemodynamic)-305.2(claims)-301.9(of)-300.4(reexology)]TJ T* [(in)-335.7(order)-335.9(to)-332(justify)-339(cost)-332.6(effectiveness)-345.7(for)-332.7(its)-334.1(purchasers.)]TJ 6.7246 0 0 5.9768 275.1873 242.0787 Tm (16)Tj 8.9663 0 0 8.9663 69.7323 227.1684 Tm [(To)-530.6(date,)-530.6(only)-526.3(two)-536(studies)-529.4(have)-528.3(attempted)-533.8(to)-528(isolate)-535.8(a)]TJ -1.1128 -1.2266 TD [(specic)-273.2(effect)-266.1(by)-268.1(contrasting)-272.2(massage)-269.1(to)-268.8(a)-265.1(specic)-266.9(area)-265.2(of)-268.8(the)]TJ 0 -1.2203 TD [(foot)-461.7(while)-454.6(measuring)-460.6(the)-452.7(associated)-459.5(organ)-453.4(perfusion)-463.7(rates)]TJ T* [(compared)-383.5(with)-388.4(massage)-376.6(to)-382.6()55(nonactive)46.5()-381.3(areas)-380.3(of)-382.6(the)-383.1(feet)-386.4(as)]TJ 0 -1.2266 TD [(the)-326.2(control,)]TJ 6.7246 0 0 5.9768 104.7685 187.3133 Tm (17,18)Tj 8.9663 0 0 8.9663 122.7968 183.2881 Tm [(but)-328.7(even)-320.1(those)-330.3(two)-321(articles)-324.4(failed)-326.1(to)-319.4(identify)]TJ -7.0311 -1.2203 TD [(the)-591.8(organ-associated)-597.3(foot)-588.2(reexology)-592.6(map)-586.5(location)-590.6(used,)]TJ T* [(which)-340(makes)-331.5(it)-332.8(difcult)-337.1(to)-332(reproduce)-337.8(their)-336.8(methods.)]TJ /F3 1 Tf 0 -2.447 TD [(A)-337.9(Reductionist)-334.5(Solution)]TJ /F4 1 Tf 1.1128 -1.8336 TD [(In)-346.9(response)-358.4(to)-344.7(these)-352.7(two)-352.6(distinct)-350.1(challenges,)-349.9(we)-349.3(have)-351.3(de-)]TJ -1.1128 -1.2203 TD [(vised)-387.9(a)-378.9(potential)-388(experimental)-385(solution)-392.2(that)-383.2(we)-380.9(believe)-385(can)]TJ T* [(address)-426.1(both)-422(the)-421.1(map)-422.1(inconsistency)-424.3(problem)-421.2(and)-423.2(enable)-421.6(a)]TJ 0 -1.2266 TD [(standardized)-238.1(reexology)-238.6(control)-240.5(to)-237.2(be)-231.9(developed.)-238.3(We)-232.9(believe)]TJ 0 -1.2203 TD [(that)-326.3(if)-320.1(both)-320.9(of)-319.4(these)-327.4(methodological)-323.6(challenges)-321.7(are)-322.6(resolved,)]TJ T* [(any)-551.1(specic)-551.4(hemodynamic)-551.8(treatment)-552.5(effect)-550.6(unique)-551.4(to)-553.3(re-)]TJ 0 -1.2267 TD [(exology)-364.4(should)-363.1(be)-358.4(able)-361.4(to)-363.6(experimentally)-367.6(reveal)-358.4(itself.)-366.2(We)]TJ 28.0042 74.5598 TD [(believe)-435.6(that)-433.8(if)-427.6(both)-434.7(of)-433.2(these)-434.9(methodological)-437.4(challenges)-435.5(are)]TJ 0 -1.2203 TD [(resolved,)-318.3(any)-317.1(specic)-323.8(hemodynamic)-317.8(treatment)-318.5(effect)-323(unique)]TJ 0 -1.2266 TD [(to)-528(reexology)-535.7(should)-527.5(therefore)-539.3(be)-529.1(able)-525.8(to)-534.4(experimentally)]TJ 0 -1.2203 TD [(reveal)-333.1(itself.)]TJ 1.1128 -1.2203 TD [(We)-447.8(propose)-452.8(that)-452.8(reexology)-447.2(researchers)-455.5(adopt)-449.7(a)-454.8(reduc-)]TJ -1.1128 -1.2266 TD [(tionist)-508.7(foot-map)-511.2(approach,)-510.3(based)-507.6(on)-512(the)-509.6(fact)-505.6(that)-509.7(despite)]TJ 0 -1.2203 TD [(considerable)-280.5(variations,)-277.6(all)-278.5(reexology)-276.5(charts)-282.9(appear)-274.2(to)-281.5(have)]TJ T* [(one)-492.9(consistent)-496.4(overall)-491.2(structural)-495.6(design)-496.1(and)-492.8(it)-490.9(is)-491.7(this.)-492.2(All)]TJ 0 -1.2266 TD [(the)-275.6(reex)-283.9(points)-278.4(associated)-282.5(with)-274.6(the)-282(top)-276.5(half)-278.8(of)-281.4(the)-275.6(body,)-283.1(the)]TJ 0 -1.2203 TD [(brain,)-343.3(brain)-346.7(stem,)-349.9(central)-348.2(nervous)-351.6(system,)-349.3(heart,)-348.3(lungs,)-345.7(kid-)]TJ T* [(neys,)-315.4(and)-315.7(liver)-318.2(are)-316.3(consistently)-321(located)-324.6(in)-316.7(the)-313.6(top)-320.7(half)-316.7(of)-319.4(the)]TJ T* [(sole)-285.7(of)-281.4(the)-282(foot.)-287.6(From)-283.7(now)-286(on,)-281(this)-286.9(area)-284.2(will)-277.8(be)-288.8(referred)-283.5(to)-281.4(as)]TJ 0 -1.2266 TD [(the)-332.5()55(forefoot)49.1()-330.7(area.)-331.3(Whereas,)-329.1(all)-329(the)-332.6(reex)-334.4(points)-329(associated)]TJ 0 -1.2203 TD [(with)-261.9(organs)-258.7(and)-258.8(structural)-261.6(and)-258.8(mechanical)-261.8(body)-261.2(parts)-262.6(found)]TJ T* [(below)-423.2(the)-427.4(waist,)-426.7(such)-422.7(as)-424.5(the)-427.4(knee,)-421.5(hip,)-428.5(sciatic)-424.2(area,)-426.2(repro-)]TJ 0 -1.2266 TD [(ductive/digestive)-685.7(organs,)-678.9(small)-682(and)-682.4(large)-678.3(intestine,)-682.7(the)]TJ 0 -1.2203 TD [(ovary/testicles,)-257.7(uterus,)-254.6(and)-252.5(prostate)-259.4(gland,)-250.7(are)-253(always)-256.5(found)]TJ T* [(in)-316.7(the)-319.9(bottom)-318.3(half)-316.7(of)-319.4(the)-319.9(sole)-317.3(of)-319.4(the)-319.9(foot.)-319.2(This)-321.1(area)-315.8(will)-315.7(now)]TJ 0 -1.2266 TD [(be)-276.2(referred)-277.1(to)-281.4(as)-272.7(the)-282()55(heel.)49.8()-273.8(Therefore,)-279.2(if)-282.2(a)-271.4(researcher)-283.5(wished)]TJ 0 -1.2203 TD [(to)-420.6(examine)-429.6(the)-421.1(claim)-427.1(of)-420.6(a)-423.1(hemodynamic)-425.3(two-way)-428.2(link)-425.9(be-)]TJ T* [(tween)-384.7(an)-388.6(individual)-391.9(organ)-383.8(and)-385.3(reex)-391.3(point)-390.9(on)-385.5(the)-389.5(foot,)-388.8(an)]TJ T* [(experimentally)-462.5(reproducible)-463.1(reductionist)-462.3(map)-453.7(strategy)-460.1(can)]TJ 0 -1.2266 TD [(be)-269.9(adopted)-275.6(so)-269.6(that)-275.7(either)-273.4(the)-275.6(forefoot)-275.9(or)-269(heel)-278.6(is)-270.4(treated)-275.8(as)-272.7(the)]TJ 0 -1.2203 TD [(active)-471.3(intervention,)-474(depending)-470.8(on)-467.7(which)-472.8(half)-468.5(contains)-475.2(the)]TJ T* [(relevant)-280(reex)-277.5(point.)]TJ 6.7246 0 0 5.9768 392.5416 466.7527 Tm (16)Tj 8.9663 0 0 8.9663 401.7826 462.7841 Tm [(A)-279.6(separate)-280.9(treatment)-280.6(to)-275.1(the)-282(other)-279.1(half)]TJ -10.1419 -1.2266 TD [(of)-332(the)-338.9(foot)-335.3(could)-332.4(then)-335.9(act)-334.4(as)-335.9(the)-332.5(control.)]TJ 1.1128 -1.2203 TD [(Using)-602.1(the)-604.4(liver)-609.1(or)-604.1(spleen)-610.1(organs)-600.1(as)-607.8(examples)-605.9(of)-603.9(this)]TJ -1.1128 -1.2203 TD [(strategy,)-475.7(in)-474.8(our)-472.7(reductionist)-481.3(model,)-471.3(regardless)-475.9(of)-477.5(map)-472.6(in-)]TJ 0 -1.2266 TD [(consistencies,)-439.6(the)-433.7(liver)-432(and)-429.5(spleen)-439.3(reex)-429.3(points)-436.5(are)-436.4(consis-)]TJ 0 -1.2203 TD [(tently)-593.9(located)-596.5(in)-588.6(the)-598.1(forefoot)-598.4(or)-591.5(top)-592.6(half)-594.9(of)-591.3(either)-595.9(foot.)]TJ T* [(Therefore,)-412(if)-408.7(the)-414.7(experimental)-410.3(aim)-411.6(was)-407.1(to)-414.2(isolate)-409.4(a)-410.5(specic)]TJ 0 -1.2266 TD [(two-way)-497.8(hemodynamic)-494.9(relationship)-503.9(between)-496.5(treatment)-501.9(to)]TJ 0 -1.2203 TD [(either)-241.8(the)-237.7(liver)-236(or)-237.4(spleen)-243.3(point)-239.1(and)-239.8(a)-233.5(hemodynamic)-242(change)-237.5(in)]TJ T* [(the)-395.8(status)-396.5(of)-401.6(either)-393.6(organ,)-399.4(a)-391.5(short)-400.7(standardized)-396.2(reexology)]TJ T* [(treatment)-274.3(protocol)-279.2(could)-275.5(be)-276.2(developed)-279.7(that)-275.7(could)-275.5(be)-276.2(applied)]TJ 0 -1.2266 TD [(in)-316.7(two)-321(distinct)-318.5(treatments)-319.8(to)-319.4(both)-320.9(halves)-318.2(of)-319.4(the)-319.9(feet,)-319.8(making)]TJ 0 -1.2203 TD [(reexology)-289.1(treatment)-286.9(to)-287.8(the)-288.3(top)-282.8(half)-291.4(of)-281.4(the)-288.3(foot)-291(\(forefoot\))-289.5(act)]TJ T* [(as)-323.3(the)-326.2(liver)-324.6(or)-325.9(spleen)-325.5(organ)-326.9(point)-321.3(intervention)-332(\(even)-326.9(though)]TJ 0 -1.2266 TD [(the)-338.9(exact)-336.4(organ)-333.3(point)-340.3(locations)-339(remains)-334.7(inconsistent)-345.2(in)-335.7(pub-)]TJ 0 -1.2203 TD [(lished)-394(maps\))-398.6(and)-397.9(the)-395.8(heel)-398.7(treatment)-400.7(act)-397.6(as)-392.8(the)-395.8(control)-398.6(\(the)]TJ T* [(liver)-381.5(and)-385.3(spleen)-388.8(organ)-383.8(reex)-385(points)-385.9(are)-379.5(never)-390.3(found)-384(in)-386.3(the)]TJ 0 -1.2266 TD [(heel)-335.5(area\).)]TJ 1.1128 -1.2203 TD [(By)-538.5(using)-545.1(the)-541.2(heel)-544.2(treatment)-546.1(as)-544.6(the)-541.2(control,)-547(an)-540.3(experi-)]TJ -1.1128 -1.2203 TD [(mentally)-492.9(inert)-494.9(reexology)-497.8(comparison)-499.1(can)-495.4(be)-491.2(achieved)-496.1(in)]TJ T* [(which)-574(nonspecic)-573.6(effects)-577.2(such)-574.4(as)-576.2(the)-572.8(compassion)-575.6(of)-578.6(the)]TJ 0 -1.2266 TD [(therapist,)-272.8(the)-275.6(treatment)-274.3(environment,)-277.9(the)-275.6(act)-271.1(of)-275.1(lying)-272.2(supine,)]TJ 0 -1.2203 TD [(expectation)-290.9(of)-287.8(the)-288.3(receiver,)-292.1(and)-284.1(the)-288.3(relaxing)-289(effects)-292.7(of)-287.8(simple)]TJ T* [(foot)-499.7(massage)]TJ 6.7246 0 0 5.9768 364.2519 214.696 Tm (19,20)Tj 8.9663 0 0 8.9663 383.8676 210.7275 Tm [(would)-499.2(be)-503.8(equally)-497.2(present)-506.5(in)-500.1(both)-497.9(inter-)]TJ -8.1439 -1.2267 TD [(vention)-431.5(and)-435.9(control.)-433.1(Therefore)-434.4(if)-434(the)-433.7(beat-to-beat)-436.4(hemody-)]TJ 0 -1.2203 TD [(namic)-654.5(status)-655.7(of)-648.2(either)-659.1(the)-655(liver)-653.3(or)-654.7(spleen)-654.3(organs)-650.7(were)]TJ T* [(measured)-591.3(throughout)-602.8(the)-591.8(intervention)-603.9(and)-593.9(control)-594.6(treat-)]TJ 0 -1.2266 TD [(ment,)-314.1(and)-315.7(the)-319.9(experiment)-318.7(used)-315.4(reexology-naive)-322(subjects)-316.5(in)]TJ 0 -1.2203 TD [(a)-340.9(randomized,)-338.3(double-blinded)-346(repeated)-339.8(measures)-343(study)-345.7(de-)]TJ T* [(sign,)-470.8(it)-465.6(should)-476.9(be)-465.9(possible)-473.4(to)-471.1(isolate)-472.6(and)-467.5(detect)-477.2(a)-467.4(specic)]TJ 0 -1.2266 TD [(treatment-related)-768.6(hemodynamic)-766.8(effect)-759.2(on)-764.9(the)-762.5(organ)-763.2(in)]TJ 0 -1.2203 TD [(question;)-538.5(a)-537(specic)-545.1(effect)-537.9(that)-541.3(should)-540.2(only)-538.9(be)-541.8(present)-538.1(at)]TJ T* [(some)-469.4(point)-466.8(during)-471.6(the)-471.7(intervention)-477.4(\(revealed)-469.2(by)-470.4(real-time)]TJ T* [(measurement)-393.6(of)-395.3(the)-395.8(organ)-390.2(or)-395.5(organs)-391.5(of)-395.3(interest\),)-398.8(quite)-389.1(dis-)]TJ 0 -1.2266 TD [(tinct)-481.4(from)-482.1(nonspecic)-485.1(components)-486.4(that)-478.1(should)-483.3(be)-484.9(equally)]TJ 0 -1.2203 TD [(present)-474.9(in)-481.1(both,)-475.5(thereby)-474.8(resolving)-481.9(both)-472.6(the)-478(map)-472.6(inconsis-)]TJ T* [(tency)-292(problem)-288.4(and)-290.4(providing)-295.3(a)-290.4(suitably)-290.4(robust)-289.2(experimental)]TJ 0 -1.2267 TD (control.)Tj /F3 1 Tf -28.0042 77.228 TD [(RESEARCH)-342.9(CHALLENGES)-335.5(IN)-335.1(REFLEXOLOGY)-30964.9(233)]TJ ET endstream endobj 26 0 obj <>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 30 0 R/MediaBox[0 0 612 792]/Rotate 0>> endobj 31 0 obj <>/ProcSet[/PDF/Text]/Font<>>> endobj 27 0 obj <>stream /GS1 gs BT /F3 1 Tf 8.9663 0 0 8.9663 62.022 725.7825 Tm 0 0 0 1 k 0 Tc 0 Tw (Conclusion)Tj /F4 1 Tf 1.1128 -1.8336 TD [(This)-352.7(article)-348.4(has)-352(proposed)-354.6(a)-353.6(novel)-351.8(reductionist)-354.8(solution)-354.3(to)]TJ -1.1128 -1.2203 TD [(address)-552.5(the)-553.8(methodological)-557.6(challenges)-555.6(of)-553.3(inconsistent)-553.9(re-)]TJ 0 -1.2266 TD [(exology)-408.7(maps)-404.4(and)-404.2(poor)-405.9(experimental)-410.3(controls)-406.3(in)-405.3(reexol-)]TJ 0 -1.2203 TD [(ogy)-738.7(research.)-741.1(We)-738.7(believe)-745.4(that)-737.3(adopting)-745.6(a)-739.3(reductionist)]TJ T* [(approach)-406.2(to)-401.6(the)-402.1(reexology)-409.3(foot)-404.8(map)-396.8(will)-404.2(help)-406.5(researchers)]TJ 0 -1.2266 TD [(overcome)-281.8(the)-282(problem)-282.1(of)-281.5(experimental)-283.8(reproducibility)-285.4(in)-278.8(the)]TJ 0 -1.2203 TD [(face)-612.5(of)-603.9(inconsistent)-617.1(point)-612.2(location)-609.6(and)-606.6(provide)-612.7(an)-603.6(inert)]TJ T* [(control,)-439.5(which)-434.9(for)-433.9(the)-440(rst)-435.4(time)-431.4(can)-438.5(allow)-434.6(a)-429.5(specic)-437.6(treat-)]TJ T* [(ment-related)-489.3(two-way)-485.1(hemodynamic)-488.5(effect)-487.4(between)-490.1(reex)]TJ 0 -1.2266 TD [(points)-398.5(in)-398.9(either)-406.2(half)-398.9(of)-395.3(the)-402.1(foot)-398.5(and)-397.9(their)-400(associated)-402.6(hemo-)]TJ 0 -1.2203 TD [(dynamically)-628.7(measurable)-627.4(organs)-631.8(to)-622.9(experimentally)-633.2(reveal)]TJ T* (itself.)Tj /F3 1 Tf 0 -2.447 TD (Acknowledgment)Tj /F4 1 Tf 1.1128 -1.8336 TD [(The)-588(authors)-597.5(wish)-591.6(to)-591.3(thank)-592.9(Tracey)-594.8(Smith,)-588.1(Reexology)]TJ -1.1128 -1.2203 TD [(Support)-335.3(Manager)-335(at)-335.1(the)-338.9(Association)-335.4(of)-332(Reexologists.)]TJ /F3 1 Tf 0 -2.447 TD [(Author)-338.7(Disclosure)-330.4(Statement)]TJ /F4 1 Tf 1.1128 -1.8336 TD [(No)-331.5(nancial)-337.6(conicts)-335.5(exist.)]TJ /F3 1 Tf -1.1128 -2.4406 TD (References)Tj /F4 1 Tf 8.4682 0 0 8.4682 66.274 463.1243 Tm [(1.)-501.9(Ernst)-378.9(E.)-371.1(Is)-375.7(reexology)-380.2(an)-380.8(effective)-380.3(intervention?)-382.9(A)-374.8(system-)]TJ 1.2519 -1.2318 TD [(atic)-562.2(review)-571.3(of)-563(randomised)-571.8(controlled)-569(trials.)-564.3(Med)-568.5(J)-561.7(Aust)]TJ 0 -1.2385 TD (2009;191:263265.)Tj -1.2519 -1.2318 TD [(2.)-501.9(ϲ)-369.6(Institute)-381.2(of)-368.8(reexology.)-371.2(Branches)-370.8(of)-368.8(the)-372(Inter-)]TJ 1.2519 -1.2385 TD [(national)-755.8(Institute)-756.1(of)-750.4(Reexology.)-759.7(2012.)-749.3(http:/)226.1(/www.re-)]TJ 0 -1.2318 TD [(exology-usa.net/branches.htm)-350.1(Accessed)-335.6(June)-334.6(27,)-336.7(2011.)]TJ -1.2519 -1.2385 TD [(3.)-501.9(ϲ)-316.1(Institute)-314.2(of)-315.3(Reexology)-313.4(I.)-307.4(The)-310.9(nation)-10.4(s)-311.5(leading)]TJ 1.2519 -1.2318 TD [(authority.)-629.5(2012.)-628.8(http:/)226.1(/www.reexology-usa.net/branches)]TJ 0 -1.2385 TD [(.htm)-330.9(Accessed)-342.3(February)-337.9(02,)-330(2011.)]TJ -1.2519 -1.2318 TD [(4.)-501.9(IIR)-509.1(IIoR.)-508.1(Original)-517.8(Inham)-508.8(Method)-512.6(Foot)-514.4(Wall)-508.8(Chart.)-510(2011.)]TJ 1.2519 -1.2385 TD [(h)-10.4(t)0(t)-18.8(p)-9.5(:)-11.1(/)229.1(/)-11.9(s)-12.5(to)-20.7(re)-17.3(.)-11.1(r)-10(e)-19.3(ex)-19.5(o)-8(l)-13.6(o)-8(g)-10.4(y)-10.4(-)0(u)-15.6(k)-10.4(.)-11.1(n)-10.4(e)-14(t)0(/)-18(p)-9.5(r)-10(o)-8(d)-11.9(u)-9.5(c)-11.6(t)0(s)-18.5(?)-11.5(t)-12.7(a)-8.8(g)]TJ /F7 1 Tf 20.2919 0 TD (=)Tj /F4 1 Tf .7297 0 TD .0103 Tc [(charts)10.3(%)-6(20%)]TJ -21.0216 -1.2318 TD 0 Tc [(26%20promo)-331(Accessed)-342.3(February)-337.9(06,)-330(2011.)]TJ -1.2519 -1.2385 TD [(5.)-501.9(Ingham)-365.2(E.)-357.8(The)-364.4(original)-369.5(works)-366(of)-362.1(Eunice)-365.6(D)-361.4(Ingham;)-369.6(Stories)]TJ 1.2519 -1.2318 TD [(the)-425.5(Feet)-426.1(Can)-429.3(Tell)-428(Thru)-423.5(Reexology;)-431.7(Stories)-427.8(the)-432.2(Feet)-426.1(Have)]TJ 0 -1.2385 TD [(Told)-534.1(Thru)-530.6(Reexology.)-538.8(2nd)-533.3(Revised)-538.5(edn.)-536.2(St.)-534.8(Petersburg,)]TJ T* [(Florida,)-335(Ingham)-331.7(Publishing)-341.5(Inc.)-336.1(1984:34.)]TJ -1.2519 -1.2318 TD [(6.)-501.9(Ernst)-399(E,)-404.6(Posadzki)-404.8(P,)-402.2(Lee)-401.5(MS.)-401.9(Reexology:)-411.6(An)-398.6(update)-408(of)-402.3(a)]TJ 1.2519 -1.2385 TD [(systematic)-505.8(review)-497.7(of)-502.7(randomised)-504.8(clinical)-505(trials.)-504(Maturitas)]TJ 0 -1.2318 TD (2011;68:116120.)Tj -1.2519 -1.2385 TD [(7.)-501.9(Duvall)-460.8(WL.)-462.4(Endothelial)-470.4(dysfunction)-471.9(and)-459.6(antioxidants.)-468.1(Mt)]TJ 1.2519 -1.2318 TD [(Sinai)-329.8(J)-334.1(Med)-340.9(2005;72\(2\):7190.)]TJ -1.2519 -1.2385 TD [(8.)-501.9(Higashi)-405.4(Y,)-402.9(Yoshizumi)-403.2(M.)-406.4(New)-407.6(methods)-406.3(to)-402.3(evaluate)-409.9(endo-)]TJ 1.2519 -1.2318 TD [(thelial)-247.4(function:)-254.1(Method)-258.2(for)-251.6(assessing)-254.4(endothelial)-251.6(function)-256.4(in)]TJ 0 -1.2385 TD [(humans)-375.1(using)-377.7(a)-370.3(strain-gauge)-381.6(plethysmorgraphy:)-381.3(Nitric)-377.5(ox-)]TJ 0 -1.2318 TD [(ide)-427.8(dependent)-437.1(and)-426.2(independen)-13.3(t)-427.8(vasodilation.)-434.6(J)-427.8(Pharmacol)]TJ 0 -1.2385 TD [(Sci)-335.3(2003;93:399404.)]TJ -1.2519 -1.2318 TD [(9.)-501.9(A)13.5(s)0(s)15.2(o)0(c)20.6(i)0(a)17.8(t)0(i)13.9(o)0(n)-232.7(o)0(f)-234.9(R)0(e)16()14.9(ex)14(ol)18.6(og)15.1(i)13.2(s)0(t)15(s)0(.)-231.1(R)0(e)16()0(e)14.2(x)14.6(ol)18.6(og)15.1(y)-244.7(C)0(h)21.4(a)0(r)14.7(t)0(.)-231.4(2)0(0)15.9(1)0(1)22.6(.)-245.4(ht)17(t)14(p)0(:)12.8(/)249.2(/)]TJ 1.2519 -1.2385 TD [(ww)19.1(w.)18.5(re)16.1()14.9(e)0(x)13.9(o)0(l)18.6(o)0(g)15.1(y)0(.)18.7(o)0(r)22.2(g)0(/)17.9(i)0(n)16.2(d)0(e)14.2(x)14.6(.p)12.8(hp)20.2(?t)15.9(ar)21.4(ge)15.8(t)]TJ /F7 1 Tf 17.2658 0 TD (=)Tj /F4 1 Tf .7096 0 TD [(pr)20.6(od)13.6(uc)19.1(ts)15(&)13.5(p)0(r)13.9(o)0(d)20.3(u)0(c)19.1(t)0(_)]TJ -17.9755 -1.2318 TD -.0132 Tc (id)Tj /F7 1 Tf 1.031 0 TD 0 Tc (=)Tj /F4 1 Tf .7096 0 TD [(3)-323.5(A)0(c)15.3(c)0(e)21.3(s)0(s)15.2(e)0(d)-313.8(F)0(e)15.8(b)0(r)19.8(u)0(a)15.1(r)0(y)-314.9(0)0(9)22.6(,)-325.8(20)15.9(11)22.6(.)]TJ 26.1498 65.6022 TD [(10.)-504(British)-647.1(Reexology)-648.2(Association.)-644.8(Reexology)-648.2(Foot)-648.3(Chart.)]TJ 1.754 -1.2318 TD [(20)22.6(11)22.6(.)-265.5(h)0(t)23.7(t)0(p)17.9(:)15.7(/)242.5(/)14.9(ww)25.8(w.)18.5(b)16.4(r)0(i)23.3(t)0(r)17.4(e)12.8()14.9(e)0(x)20.6(.)0(c)24.2(o)0(.)21.1(u)0(k)20.3(/)14.9(pr)20.6(od)27(uc)19.1(t)14(_)0(r)21.4(e)12.7(e)20.9(x)14.6(o)0(l)18.6(o)0(g)21.8(y)16.4(_f)18.6(oo)24.2(t)14(_)]TJ 0 -1.2385 TD [(ch)24.9(ar)21.4(t)14(.)0(h)18.6(t)14(ml)-310.2(Ac)22(ce)21.3(s)14.3(s)0(e)20.4(d)-319.9(Fe)22.5(br)19.8(ua)21.8(r)16.8(y)-325(02)22.6(,)-319.1(2)0(0)22.6(1)0(1)22.6(.)]TJ -1.754 -1.2318 TD [(11.)-504(Ingham)-244.7(E.)-237.3(Stories)-247(the)-238.1(Feet)-245.3(Can)-241.8(Tell)-240.5(Thru)-242.7(Reexology;)-244.2(Stories)]TJ 1.754 -1.2385 TD [(the)-465.7(Feet)-459.5(Have)-459.8(Told)-467.2(Thru)-457(Reexology.)-471.8(Ingham)-458.9(Publishing)]TJ 0 -1.2318 TD [(Inc.)-336.1(St.)-334(Petersburg,)-338.4(Florida,)-335(1938.)]TJ -1.754 -1.2385 TD [(12.)-504(Jones)-258.5(J,)-258.2(Thomson)-264.1(P,)-254.9(Lauder)-260.4(W,)-256.3(Leslie)-253.7(SJ.)-260.4(Reported)-264.5(treatment)]TJ 1.754 -1.2318 TD [(strategies)-623.3(for)-613.2(reexology)-621.2(in)-613.2(cardiac)-618.5(patients)-623.2(and)-613.6(incon-)]TJ 0 -1.2385 TD [(sistencies)-348.3(in)-345.4(the)-345.2(location)-347.7(of)-342.1(the)-351.9(heart)-343.9(reex)-343.3(point:)-346.5(an)-347.3(online)]TJ 0 -1.2318 TD [(survey.)-328.9(Complementary)-324.7(Therapies)-332.4(in)-325.3(Clinical)-327.8(Practice.)-323.8(2012)]TJ 0 -1.2385 TD [(18\(3\):145150)-338.9(Epub)-329.2(2012)-336.5(Jun)-334(27.)]TJ -1.754 -1.2318 TD [(13.)-504(Verhoef)-308.6(MJ,)-305.3(Lewith)-307.6(G,)-302.2(Ritenbaugh)-311.3(C,)-307.3(Boon)-306.1(H,)-300.4(Fleishman)-310(S,)]TJ 1.754 -1.2385 TD [(Leis)-587.6(A.)-586.8(Complementary)-592.5(and)-586.8(alternative)-587.7(medicine)-593.3(whole)]TJ 0 -1.2318 TD [(systems)-438.1(research:)-430.5(Beyond)-434.9(identication)-441.2(of)-429.1(inadequacies)-440.4(of)]TJ 0 -1.2385 TD [(the)-338.5(RCT.)-329.4(Complement)-342.4(Ther)-334.3(Med)-334.2(2005;13:206212.)]TJ -1.754 -1.2318 TD [(14.)-504(MacPherson)-390.1(H.)-380.8(Pragmatic)-382(clinical)-384.5(trials.)-383.5(Complement)-389.3(Ther)]TJ 1.754 -1.2385 TD [(Med)-334.2(2004;12:136140.)]TJ -1.754 -1.2318 TD [(15.)-504(Black)-906.5(C.)-903.2(Assessing)-908.3(complementary)-910.4(practice:)-906.3(Building)]TJ 1.754 -1.2385 TD [(consensus)-456.2(on)-453.6(appropriate)-456(research)-459.5(methods.)-457.6(Report)-452.7(of)-455.9(an)]TJ T* [(independent)-581.7(advisory)-577.6(group.)-580.7(Introduction)-582.6(xi,)-579.1(The)-572(Kings)]TJ 0 -1.2318 TD -.0233 Tc [(Fund.)-262(h)-.3(ttp)-6(:)5.8(/)]TJ 5.0077 0 TD -.0218 Tc [(/ww)7.8(w)1.1(.ki)4.8(n)1.2(gsfund)6.4(.org.)7.3(u)2.1(k/si)4.8(te)4.3(s/)6.5(l)-1.9(e)4.3(s)-.8(/)6.4(k)1.3(f/A)5.1(sse)4.3(ss)5.9(ing-)]TJ -5.0077 -1.2385 TD 0 Tc [(comp)15.8(le)12.6(men)13.7(tary)18.3(-pra)12.5(cti)15.7(ce-)15.2(Buil)18.3(ding)13.9(-co)14.6(nsen)12.9(sus)19.1(-on-)16.3(app)12.3(rop)12.7(ria)14.5(te-)]TJ 0 -1.2318 TD [(r)-10(e)0(s)-13.1(e)-14(ar)-12.1(c)-11.6(h)-10.4(-m)-14.8(et)-20.1(ho)-11.7(d)-11.9(s)0(-)-18.5(D)0(a)-15.4(m)-8.7(e-)-20.1(C)-8.3(a)0(r)-12.1(o)-8(l)-13.6(-)0(B)-11.3(l)-13.6(a)-8.8(c)0(k)-15.2(-)0(T)-18(h)0(e)-17.8(-)0(K)-17.8(i)0(n)-17.3(g)0(s)-16.1(-)0(F)-16.4(u)-9.5(n)-10.4(d)0(-)-11.3(J)-12.7(u)-9.5(l)0(y)-17.2(-)]TJ 0 -1.2385 TD [(2009.pdf)-334.9(Accessed)-342.3(January)-331.8(04,)-336.7(2011.)]TJ -1.754 -1.2318 TD [(16.)-504(Black)-906.5(C.)-903.2(Assessing)-908.3(complementary)-910.4(practice:)-906.3(Building)]TJ 1.754 -1.2385 TD [(consensus)-710.6(on)-708(appropriate)-710.4(research)-713.9(methods.)-705.3(Report)-713.8(of)]TJ 0 -1.2318 TD [(an)-514.7(independent)-521.4(advisory)-510.6(group.)-520.4(Summary)-513.6(ix,)-512.2(The)-511.7(Kings)]TJ 0 -1.2385 TD -.0233 Tc [(Fund.)-262(h)-.3(ttp)-6(:)5.8(/)]TJ 5.0077 0 TD -.0218 Tc [(/ww)7.8(w)1.1(.ki)4.8(n)1.2(gsfund)6.4(.org.)7.3(u)2.1(k/si)4.8(te)4.3(s/)6.5(l)-1.9(e)4.3(s)-.8(/)6.4(k)1.3(f/A)5.1(sse)4.3(ss)5.9(ing-)]TJ -5.0077 -1.2318 TD 0 Tc [(comp)15.8(le)12.6(men)13.7(tary)18.3(-pra)12.5(cti)15.7(ce-)15.2(Buil)18.3(ding)13.9(-co)14.6(nsen)12.9(sus)19.1(-on-)16.3(app)12.3(rop)12.7(ria)14.5(te-)]TJ 0 -1.2385 TD [(r)-10(e)0(s)-13.1(e)-14(ar)-12.1(c)-11.6(h)-10.4(-m)-14.8(et)-20.1(ho)-11.7(d)-11.9(s)0(-)-18.5(D)0(a)-15.4(m)-8.7(e-)-20.1(C)-8.3(a)0(r)-12.1(o)-8(l)-13.6(-)0(B)-11.3(l)-13.6(a)-8.8(c)0(k)-15.2(-)0(T)-18(h)0(e)-17.8(-)0(K)-17.8(i)0(n)-17.3(g)0(s)-16.1(-)0(F)-16.4(u)-9.5(n)-10.4(d)0(-)-11.3(J)-12.7(u)-9.5(l)0(y)-17.2(-)]TJ 0 -1.2318 TD [(2009.pdf)-334.9(Accessed)-342.3(January)-331.8(04,)-336.7(2011.)]TJ -1.754 -1.2385 TD [(17.)-504(Sudmeier)-271.4(H,)-273.7(Bodner)-273.8(G,)-268.7(Egger)-270.9(I,)-267.2(Mur)-274.2(E,)-264(Ulmer)-273.8(H,)-273.7(Herold)-273.2(M.)]TJ 1.754 -1.2318 TD [(Changes)-436.4(of)-435.8(renal)-438.4(blood)-433.4(ow)-432.1(during)-440.7(organ-associated)-442.5(foot)]TJ 0 -1.2385 TD [(reexology)-855.5(measured)-859.4(by)-850.9(colour)-857.3(Doppler)-854.5(sonography.)]TJ 0 -1.2318 TD [(Forsch)-337.3(Komplementarmed)-339(1999;6:129134.)-339.8(\(In)-332.9(German.\))]TJ -1.754 -1.2385 TD [(18.)-504(Mur)-267.5(E,)-264(Schmidseder)-268.1(S,)-261(Egger)-270.9(I,)-260.5(et)-267.8(al.)-261.1(Inuence)-271.2(of)-261.7(reex)-269.7(zone)]TJ 1.754 -1.2318 TD [(therapy)-470.9(of)-476(the)-465.7(feet)-475.3(on)-473.7(intestinal)-470.5(blood)-473.6(ow)-472.3(measured)-471.1(by)]TJ 0 -1.2385 TD [(color)-278.7(Doppler)-285.5(sonography.)-283.5(Forsch)-277(Komplementarmed)-285.5(Klass)]TJ 0 -1.2318 TD [(Naturheilkd)-337.4(2001;8:8689.)-335.6(\(In)-339.6(German.\))]TJ -1.754 -1.2385 TD [(19.)-504(Wang)-368.6(M,)-366.2(Tsai)-368.1(P,)-368.8(Lee)-368(P,)-368.8(Chang)-369.8(W,)-363.4(Yang)-367.8(C.)-367.6(The)-371.1(efcacy)-368.8(of)]TJ 1.754 -1.2318 TD [(reexology:)-277.5(Systematic)-281.3(review.)-281.2(J)-273.8(Adv)-273.3(Nurs)-281.2(2008;62:512520.)]TJ -1.754 -1.2385 TD [(20.)-504(Siev-Ner)-389.7(I,)-387.7(Gamus)-390.9(D,)-385.9(Lerner-Geva)-397.4(L,)-384.5(Achiron)-391.9(A.)-392.6(Reexol-)]TJ 1.754 -1.2318 TD [(ogy)-490.6(treatment)-499.2(relieves)-493.7(symptoms)-498.1(of)-496(multiple)-490.3(sclerosis:)-500.8(A)]TJ 0 -1.2385 TD [(randomized)-333.8(controlled)-341.4(study.)-335.9(Mult)-337.4(Scler)-339.2(2003;9:356361.)]TJ 8.9663 0 0 8.9663 441.5243 253.7007 Tm [(Address)-339.4(correspondence)-340.1(to:)]TJ /F8 1 Tf .3225 -1.2203 TD [(Jenny)-338.3(Jones,)-331(BSc)-334.9(\(Hons\),)-338.5(RN)]TJ -4.3186 -1.2266 TD [(School)-331.8(of)-336.3(Nursing,)-332.1(Midwifery)-336.5(&)-336.5(Health)]TJ 7.499 -1.2203 TD [(University)-333.7(of)-336.3(ϲ)]TJ 2.3901 -1.2203 TD [(Old)-337.9(Perth)-333.2(Road)]TJ -1.4543 -1.2266 TD [(Inverness,)-331.4(IV2)-337.9(3JH)]TJ 1.0686 -1.2203 TD [(United)-337.2(Kingdom)]TJ -6.0257 -2.0549 TD (E-mail:)Tj /F4 1 Tf 3.2563 0 TD (jenny.jones@stir.ac.uk)Tj /F3 1 Tf -45.0634 64.7023 TD (234)Tj 47.719 0 TD [(JONES)-334.9(ET)-338.7(AL.)]TJ ET endstream endobj 32 0 obj <>stream hޔWytSO hxɽ~V@@ep`,HbyL4I6i3O7MitN(XDw}u-S9ۿ{F6ؚMWG-ZQWNC̹ qta1LM -h40ڣah ,TڒWhh-Si1mJFӆh8aօ)M?5iӼ~QRWuӿ}$3v`fƣmaegmuu~rz΂9B31C/ϱ,f@Y\D"u{y˗;y$(I~6 OٻӍ~f^2*QXnD+nT29ˋˠvM!iQr4Uh"8; wgFu?5Ɲ?aR2"k>/:aLGkǵ.ȲпN0.ݸ2<taBW"yvsMղ0|\@2:* ڐcW<.T@"|t&a@б}><`wR/J ׾}qb41J‰cعr| 9 ]N>a:X9#/w{#:/} |oUW)IEEޮnY^*3K1iM9 &#/9u~dtۧ^KTa 9G0-+z|@'>wYS=b0lrLR$f,0 "Q͝-V$n2>}Ԃ_&W](ewo`bfjۅ#s?5&p*rJ6jI~-ufUI+0 Ϡ@fjaj|5EjM+\.K72p$&0+Pr6RAHf!bzm|1=0'`FV`܋@y5z[@cvY\Î~.۪LWӍCr2YɘD{o@4<IM%S=x2JW*Ԕfd|8`2ub](лp2&FӸiK'Qz羉x#@8m6T {">Ga3?,U7qu>P1ЀKt q-6҉O$MEV5fB:F.zsT4[[Lp(Ѯ|L!乑vS8fG>ɏJŒʦb4ch*=:nbD,&XAR,.-E'ȹq) Yfw3XD]C|'|Lɋ#M+&?bm &leҝzVDzMn*L $ Up%QUQYZG~ sx{ 6gMTWw O(*8Lx"CwP=dϐn |jъgdQ 6-չ<3hb{Edha` +8jq9x ƆbC6cOOp'"cSIo[bhDޜGټ06ݞ5xFQ҃x ,,wU1'o(r'7[_&HڝK6=:fHxx|ꧣ8`r%(43 X, ?~r%pm:]Ʃ0@6s:9+Z!yf[gC&PK)-OC(i?6Vm CuTz,{y|$S,:܄Cuxȇe^zVcVщp^LnFb{벑R|'(v_u+T\) H@,:5L]nnЮs#W-& xj[]A/s-OlgԈvيdػ)$={ԕddkݘWmEj}zm%Vq`&0P1zi;HxqNNv;}`HVUWoAg)Byu|C!n(fk%r5Qc+Db Ra2rv8k$Y ir5XTmַOj!UiV( lrw]->7&iwn +J*Kd%OKܵFPMlICbD}ÍD-Uby42*>鬖''H0,[a0}YGSEVUF//D4{^i״#-Je=A(ͪ"*9W`y6(FzW]PƗEtC~+KY=ʫ &lN1j .%N4^o9TR_@GTmn5"_LB`ݸsymA*n9,t~&y ^e-uUfِBQJIP^)wjDg%&(`D)E[V6_ʁP /}1+dzD'dۅorU^\?ۭ-sUX銴<\*9^q_-,JR9ݕՋNTWjܷ"|!5l*y7XnC 7,6O\61ȰM?r{1Tj˪%.OP%k(wևM*L/\D7& Eƴ|-%YC[/!j0IKXlNT|;8ns'7>9!hhSɘti,*X WϜ46=B5d= YBrJaD 3Zˆ'e_:?1MLMbP]Ŏ F <,zĒ$ /m_{dK`a̳J]j6K < cYz Vg"qQYB(/7IFQqV2~$)JhS0[Bsi6l `j:jNZjD Ide Cѣ "6t:[Og귻r'I˸h$-ܱճ3(SF;#4G7΃:ڲ?@ҹްe.败=p<b+b@#9%JwO⼟) vB`[Y'AJ=7[B6@jy\+! D rCGښ@gk k=Q줝H: SY!fg` endstream endobj 33 0 obj <> endobj 34 0 obj [/Indexed/DeviceRGB 255 35 0 R] endobj 35 0 obj <>stream 8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0 b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup` E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn 6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O( l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~> endstream endobj 28 0 obj <> endobj 36 0 obj <>stream 8;Z\7;&7(]%!7m9jo/o7Fg_a:+JHrlmWL^@>O=2C,6@>R'u1"rerIHQAE>j*f`,jT jZ[9!;^:+CD$$AZ+a$CbU_RpE".$+?(+IV:6I1_-Ytfb39_=hX8Su=TS+pM8 !q3Vj)8a5s4p[l0EdGk+P@^ZeWpkh=I[hM-X\,'5qfCnXk@&1>o*gk)?u&L6.dRPd -!lYHA`=]KfUs"WQ`O;/=+MOk:I?^O2,urGnm8%rY<1//j\l(O021.\lCCLXmd9FOag1\ OdD`n6pVO:]i4T*[BCYNnbLkBl8;kXU%Kf@0da=a:*6[6YE\hDhcZi. (l!9TEPLeB\?.sPC:n<2=D$MqC@(bXU,%/mnP0A;*q^Oh?*@KPfj>DjGUIf55]Zk2 $6`<9[s(A56/rFW##4Eg^^?%]qSQ+[rT#nAZ2K@7g"6B*rnufA#onF+n&]5M4p(cb'hst~> endstream endobj 24 0 obj <>stream 8;Z]"CJr&(%"r\hrq$*7ZIaXAgfUj'hF%C!W>O)\6bQfU82B[p'@GO/R:GK"DjON> D%");g$P,*D-um:eC?b?&d.-+W)khn?/;^]I.?3Ch;PtB"Q-7_YND@pgbIlR0TL#2M][)9J0! #Ab9*`S=OLXI56^F*[Em?[?[<.+Df]E'0`O$X+"J?6=T\lE_\D8/SQ*"e'e#Y>ehd Fb.o)jf`F5&F"eM.uVRJ`J'r/a8.d@?W`3L$U[GBf1%rRnSYmrV>V8F'34$`rbg4; m/6W!L;TAH)RkL;NW#@sqlfdb[B?#QIk^3>enp/FaakR=AU^%Q.=,Uhp5o*hkXsGN pkl?jX"35rU0iQ(g4&]%?[CNtcl^lSierMgfK@3QIolBbaZ]<"$27,(DYZ<:\p#E8 ;1.a`38F^?*uFlZE\?D17>)*WJ#]"p!JPfUD~> endstream endobj 30 0 obj <>stream 8;Z\7;3n"3#im]=EW<@aSK4C2@Z7R7`nhg%B,`]T==FSdp=^P9ji0rOWijC7Hh32Q Y.qlpnPmKgVeuG%/bLJe3i4\.jn&6KULun(YF1becun/d#0>"=7gdnQj^'C?lT^M: )'0SY!I/]-ebY"jk',7KG^aKV+%q&FFJpq\R9qb_%-n4L$j-ap2UbFJdeLi$?h1PB qnAek^[RDcUZ%#B[IYFZ=]'8$JeePd3ud1DG<)?7,LS+\[c9MqFNgrUp"(Ii8#Qo5 %S&<"1/Qg0<]k+WT&\^V_R\XZs"XUAd&ocYe5\R_D+tmt%EC0p %D=EDSbHu(^=P#EAadE=ZLsGVe8*r#4JTLEn;Frr(##FJ*+[!:.-AQRa._+7CaU&; 4>J>apAU'9LtE>T&K0LrrKVX@Qq[d8nK*(7l^M9$]cWa3tcBAMr.T.qY,((*Xs<^gHKhg%*AQ]Y2U4q2P%@JX9urY'Eq `b[D%KG/I(oJAoO6MH``mtd2!)L>paDe(7hf#C endstream endobj 37 0 obj <> endobj 38 0 obj <> endobj 19 0 obj <> endobj 40 0 obj <> endobj 39 0 obj <>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 36 0 R/MediaBox[0 0 612 792]/Rotate 0>> endobj 53 0 obj <>/ProcSet[/PDF/Text]/Font<>>> endobj 49 0 obj <> endobj 50 0 obj <> endobj 22 0 obj <> endobj 23 0 obj <> endobj 56 0 obj <> endobj 57 0 obj <> endobj 21 0 obj <> endobj 41 0 obj <>stream H|Tn:+)mP#..x+(϶R.0`HΜ3goYjqqTO h"IwT'R1*H"//`U5}[|"ued;y9ٙXOOL{sx3 7M3ŚBɚQƀIu Sk)3qZw1tF[u+N=0Mi"4{FDU!3ֹ1 `F{ ]~]Lp É7z71]啔|P.ny,eIKel2h)HrYR%3D@O:'w7~u} Hy-׊aH bH*KxL"ɕZ ! [V^iEZwz '&؊2.yed@;|\^ICeD%9 l|gI6*$-D /R76<"{fnb'O#sG5SY3;ÆidsB귢-);++P(eVuqŮ̂l$OUe#~u=EW@̮0RDe "iq>Zh4kw:+ykSCOX "L.K*bQeXvxh}Pan 5*%~0Q Gp5}XP?1Sc  HeVk k7b@6;\@s3H_- Is}(gY(4.!`5ovj-C$NO/Jk=D己1{bDQc7WC'aEY/?'! endstream endobj 51 0 obj <> endobj 52 0 obj <> endobj 42 0 obj <>stream HlU˒8 +HoUH*=m+D[H3㟝ʢA+&"4 /c__ncTQդO8E#EY":#HVEi(|Uؼu)>PkxsD3Ύ\.:K';gFE=Uń؍uɠA×ӝ GٔTuc0e#→te F*zyBmዤ@wŽ|DC"7&j>\rxR|&o FTU4:3P"bTs*^#vh&P ȃQ/YjwGk94tACWكQ Dc]Kp}+טX0}]b: T@Yts9^-|6#ì~H)hKI$aZʧcUTCt(@UMoR 4GJI(YavUԗ-ŬX U˻hc"DizHq \gg$Z?f(Ix{ڼ.2mqjE+aTdݱ] @ˊp}q9o!qi"'dcVB+QaWl;>T% , kƂ[ߺ̯&I5XoRkՑ1 I[^4?&3uɢ:*E(ű9%KRPM_qBDY=E[wmv(ਦIUQ )x$- 6` ruprcP<' endstream endobj 43 0 obj <>stream HtTn9+HorAgo@K< i8 kW9d?go.9 .GPr5Nw~\Jޟwː_,WF\؀h>՚)|̇X5:ϱ41-;o")s<$ z(W~Inb,)Rjy+dqX+@xʸ:1{B欜ﴰP,i̿OWǵ[EeoP[>|l }Qrma@z7>:SYӳR[kIaEyAR+܇VxW#A5M HΓ'MhDoZEp3ՆM~3y׾Rp^sU\&gf2(#:Zz)JJvhOeoI%O\'X*&/uO'Z(GZ.tK,K3LpgtG2'(q^/܈_Ɔo Wn0jA0{\_jBo[`3=ԏ43 endstream endobj 44 0 obj <>stream HtTr +|ĝ !tL}@$bёApmoII:>X}i6~|J-Vmifl;ij.ytaqK\ .e6oL[B[;fgWZt}Jvjn+vZ}8Й ~M>+8ådmؼu=!5QZ_˻~ ɭȮd[>5rq9!TJz\6"J 6p1c8k";|S `@ KNZ {blJy.<Ҽj4kPRI 5* NI lZ0h)h_wӂ4zBh *&tDNWQ9D^^B̛K%WI)CweB@Vy.'T6f'>Z&cOΥh]OP"@u =v.erBp}BO;4 X ;E 2P5ƥfK|>stream HlTˮ6++U|J » Zm6hu ):A5̙sfs%0fxTm]u3śǯ8h[Jc1Uzɖ`-QCFeN4U5^  ۱(waҌh -/.Fv p2ZE /BߖD pB}ƴ{ vJr/*BM;ּ0}%2Z]W$TEvY}zEZ)\!tΩZ */#| 1U\+%)*x[=ҭx] v+3{ǐ(jrs0KҠ0N4dJ %kUF%-2h5-P.װhՀ$يM5 t G-8ɜӀ ݀!R A>tbcNi jZ0oXRZ P@F̆!|+Dj&2H)L>`,g;Ti+Jh~Y܈G1Ѣcbt[v,J*[ΥC.W,^i?N[dmɜ[ݑ\hrzE yu˜>;dr4{);ͧ/ endstream endobj 46 0 obj <>stream HtTˎ8WH.bB|K rq׷E!&d ?;U``.rl2&&AYq[ckeD[Ո>VAXFՌ ӵ|OR[4P#rnT㑫 nnv? ۺT-!}.>ʰ('cs:=)Ֆځֆ9Þ4.۟q4)('iPD2R*u>tȋ^ޖa^ў9" > endobj 65 0 obj <>stream hbd`ad`ddprtvL) {X_++F9n1L2c)?B~,b-a\ Ѷͫ3VP pmywӳg>G [g~uaqiB~~]q9:[{0}ӿ"@rž|B[ i@=o endstream endobj 64 0 obj <> endobj 63 0 obj <>stream hTMo [@vVrX7- i1!:퀅?;w"w#8 GGP7`Wt~#N Vȏ#{y~ ";aw?R_B )BJAӫ=!ȌŮk@h_o9hiDhVA$?';q̷fqYDⶊ!c椳^d!qC`tyk endstream endobj 62 0 obj <> endobj 47 0 obj <>stream HtTn0+x$)^=5CЃc˱[vd'M6YJӴ˙ݙfUMA[YԤQ>V6𶨮}o7O*h'5NGaSlFSIS Nv%FdjtѕS㫋NDA.i0n )"XXA$[Bse$miW<]֍ꑶ/ Aܔ$O廑OS 5?im9٫^Aץ5\8T/S1]ښL9hN3sZӆ"e" "|[NVHv7hJTX;N{Q exc̣6kמ ^ۨ)7~'z.YC,B-6u =nwǂNXbQymٷr[ɴ!=fo#S=B]”crpH0;^"x[>"sRg2,8kEdsp92R "6@ aRSR,[p?\LCcC;Ǡ|'\n#H$ħ!1vhj#?N*``8};a{qwʭbRݦ]9ηk鼷p i~RܪF%Todm -ߎO"X+Į jjؾBB*S XotM7j_/#Cߌ] *)}[04azIҝ d endstream endobj 48 0 obj <>stream HSn@+Bר̰WqIb&ȏqA%OΌ,B^xǵ$ZRP|_JA&#o]WBP"?Wmʞ%}.ꍫ&1,LYG[%࡭DBMxqЅFu<`58ٹ=ﺆIdD0.IHA J[uDՈQl_g%J9 @, 8 pֵ1O G̴Coƌ~Wuuw,+o$MY7|:U[O)ՁJNbsR,R&./[`,R)2KEczp=y 214/y61K# ƅ1z]̟'۝m'F p89 N'r"UKx;6_>*t*m2eevPM|s,=bTrۄ.dl9,7kk}@DDs)ܿ!E endstream endobj 58 0 obj <>stream hތUyTgJ;-52:*+`t&0A@ĨAxIt՘hXhb$x&dqjkLo^WU}*FfT*ı˜{ȑaU,rY3VW|MLr9Jb\ht[Xl+td:.90*z M1L 0jfcX&ŋIS3y Nh-Lc2*oBUZRSFGj+kק^4FEC aSNIDgZQݠmuYtut׽;y?$ЋCpi&wƳSc)CӲзQthT > yo=tWzA Ha%\.?^nnO [!a1` 4k_=0a8lxݭq/l`44 b_ ,vh̭Z}̅>l$' Qm,\Bq҇\%YOe{d #N+ )0@.M$F:`泓.fV/kK}.F7pB.8%vF>[ۤcßԅE9J5²0<۔J)9 _7?4Hƿ}`v {I0qU44f q3%7&m[q/lE nj;AAP4CWԥӆ ]rXE@Hg+ViګU.A_"&']dIo'',&`` 2#:LP,9> aEƷŠ#p㊣†y0 o2 gC 9 3x}*o5S@euow$*u@IpިyްzmCM$b0&o??j =0(ͿA*LҶmH' PEG\08<7fT3\n1WYSⴕ'\0 { ._Uʶ~4?0"v^)HmRn+)mK$ocq>| 88_b!@OpCY),'/\fqb=zm) PEF{eu5seɹ:X8`ŷWV.YA-d^Ղ  7.)cBTcûgk֬_I.}+6R:"mXJ2i߅F#D4 )>złҶ ̹ zAT_^YZ 1 ?e1:ԜPH z?0WnzlD`3&a& 1Hdo{av=%=s2J2.d X=ObG'hQ=#@wmcMg rw(?o!{jN%7zl~f }KNQKFI;Xv>Ac$hPfkgeYbھ})*Х5 y2>|~lԠ1/v5Hc> 1)sf) >½ʱ<(H䤫NN-L )c vӵ6XS.g |c;J1og&gen ˜]*?G n-'V$gTĵ b$zeLʙ?9MeӦ"׆pJ X 2%7?9,QYiY;n ϡѶW >oΆ𱷷(ŵh`fʽ[!Yس88< l 6b|\0ˎt=NA ^ 6d0@4z]Cڝ--Y*^a=ZazH|BF׾ ~֖/ZT8zǾaRc< P0c+}*ŀom`ԕ!D+B_&y'K;}A2sYB"q(+ Fz, #aCB%J*9@ygb844;r4㛋=j7Aq5A JoE|[' endstream endobj 59 0 obj <>stream h޴YXdv$uL$nlA(*ץ,җKf,])D{1Q4&gy?<3s}Woxfۭmbg o…?ԃ!ȥ_yk :#cc353hx%z(hwjfxqq G&<7ML&=|ӫJDt xۨ==g^ӽcƎIl0vخqn>o1 '\u➉19[ڛWNN6 8 ĭֽLM  1u괩קU04J&l s\kݷ>>*Zrw> ÿrh*Loސɯ32Lt+f܄m ~Q #tBg5eI4!- .tApC[+W{Nmyvetn>$9ZNoz\ċJ3Jne'_]#t؉,d_kpݭ.5vQ_VeO6}!x#ޝ}?㗻?mT$'eAkB׺o.I `/80| f Xg1bhC۫ ̆{afWŁzcpḃp4j$4bA`y`jR5raGn6~%v 5Ky+u2i\&X[[_V" I(At0z9X xkA:X;ze0壹L4K1`Z$8$KH:+Fšy $SF;Pt4}ң{TLT +U+4Qm2,L$(̵k''hgU LB~:D 8 8}h%|wGw2-5͍ ĝf$p|t2HS~ '++Ǎ+Y&MG4םvK8?soPJ\P7St𤬉ӹvZ6b=Hhzts\ܦ@8Gcı4}BP0u)So!Hh/`P rw5S<~PZNݹ^iKڳ*;*#C M3OHW$4uFo-h\?H^V.J>ZGL0fUwt ܄~^T9 0~et ߁>d07bZW\`p0N]_Iu?YCNj|”2%DI)MP?؀υ|r=a23& t Y=)%6o_ RG͵x|A fGZSm\\zh!Y3Dbq<7י-y >'˿*֯v6{܁z"(6iה+ӡ9ފP>vÝX1&+5&g2ٲT/PEǃrȊ$ʳոw=Gѿu2;0^)9킲+O#'FԐzxɭ7'q',r`@?n.lx稡Kb_ە`!V.b15nbb"pC&h94[(P6 o^.THJ]+Ⱥtz h" qYLZ4Mn8Mܾ@U+/d-h>q؏& K#Ó(iiaZn@X50!F|GEEw||%Iީ#, A[BEN(WΆAo_p:;4ɆLnex`[gj;QZ~H$QR4Hp :q9 8`ڕ.oz0ܢ=Ls,s^T=n[O8[ ܣ6o^j4 w94M;B>L+p㚙gI( kⰵ?:[w9@p 3 2pzw)= 9Zǀ70_exLO)"#WĴo}8s^Kv$'Q$2PUCkV/q@fjV)LVXϣ[mx+t!=t2%#S&N83Z)n1Ǩ<#O·4S$Ƹ/PO{tao [8_g^fy<#D,ёȲ5 obL9n/]K@/N/vq1tXb(XauMGth C V{X곲 I&h/ۋa8o!:e^r$gsp kcud0UqADžv%\vBKIhw&% #%jG2G e kn$kiJ3l oӇns4\!%#Sc}%<]t.q8`7,JY$ )N1KN9fM :[Xq9%or=J>D9)ɪ#R)gN>t#ܟ&C.N-퐗֩ҾNT)`nX)UV#;~_s;*tʊh AAXVU n 4lJ?eF^8==B'I9,zRE6_)^J,}ZNJ:UýKAxx'wLBYׇ s9 E܇ð]%KNJ+ ژLFpQW(.q0IV%pvw fk udǗ\s~*4&`ַr㰾!#*a`$a)O}CiP@@n(͎\ޯesH0nrd舚|alF,KKq`}ObprقҊrԅ9y.A54Wfe}A`۷s<ǘ){REa'JU\$5fB>LDHD!y7kΪt76߽Sok{prw[MO\a[̛͜*Hn4#yd>r;"((9) FJ^!n6q8ׯ%4[DYt,?mLd Tk#ȍJ!W1}BN4 L|&c3dvpd<;3_Y@kkqna %ޡČ=?~ O?QQg[1p r Vͧ,2+WqS&,0T@E%G'&]l.xݮ\R{ IDF8pg`4=9KY8@̮@'N e!ᔝ5f{0-xfڙ#đvn#`ơL. x5Ur~0l1XMGf!ŮEW-4q/&Z[$EVu]4q(x B\ٶFmq1Er򰧯j:+SKn6N_j::pœ9ԆɃu**PsH] %p{v{vqعˇWgLO빵(0vG{ǦFl%0/Kk. kE+4JFqWb Z^/ CB7+v[ΔoJ#C"dM }TS-o0VׅJCCk%zJߓFd!Qf_T!GUFUTcCuKMRT?ڹk?7T 99/V$g[Z/-V{кȥv$=6rea#pD]_;o뀚/܏IIpp$B39h> IM~$ &hLcOfө5e]C*?9y&'HUK dCYkσ 3{n_. Ssnĩ?qʐvd)o#c wB'"4$5%Z .>wJӕ. FlݻFϺ/t5s5=W L3G/ttTDE|ၲʁ_ʆv NJ%8jr Y_R늂E:4U/(p!F[Cz޸n9!,\;8mXutNC vf"U4dﱤ2$51VNx&UPLB)Hک>M rq\0&tM " YVQ۬,v$AK3FͲi-E5uyO)QJHe`a/'V\_\6:tx&G0CYOKX(hW|tH;sYan҇ane9(ExMV]`&%I@/`G,zpӁt)k%'>rĕsg[ë|ePXsՍ$VAA#N* Epj+KQЕK֥E^cF~JS++)"` K]Neb3LQ"PVOEG *Sˈ;-}WvՍ܇8w'aN٢('gFlx:W|*s`WxfLؐPCCrbLAO47Gӫ>LV#Q[DMfk6ްfGCK,%/vG ! Ha+)ǸrTQ_A*:9mEqN)PI_`=;J endstream endobj 66 0 obj <>stream hތU Tg9{D"GP% /1 xDh$ޫF\}Ѭ<$1!b0*!o=vz絛JF)L&{%$"2"f{pj^P6Je({ 1㯫,;h0;@-w2YyMhfV9mؔq >rrѩM̲ݳ6ڏTjʤگj<(f; γߤFCMT`(ؚ;>y%/ {9c=c",/[?rai pIeɩ ]8.dH>KEPZL&o *|EݬFHe[?cXלi s<# eaud6q͆/.v4 |rx**K* /:~_mzQlcT{$[sIڴA7f /w@; ⁝_x%s_

5' ՙ.676$nEŞ>0*11HTNX5W,-wP녢7q/Vv`ra @U=.; W?=yIo.U(/wMt#rw^LNXF2}xVL6p`Xɣ W>8\r z2eIF Lu"> \тY{/AfAsPocN׶&&w51i5Em:H*HXRW7PV{Wrx*i.wӻ=Y؎ vwْkJBCnXvIsIx`Op1Rjmꂳ۱緻ᓱawpǛJ זK6V-H5x Z:j~+G2X+|uV!= <Ѡ` `sMDi*\!k(\goT Eۋ*x+ AW H67ڿsLj"5ZLZ endstream endobj 54 0 obj <> endobj 67 0 obj <>stream hތUkPW3LwQ0vNǾ<!ȨuE(>6(\u(P*nD(>J jvg&gj︩?>!:-h4kJx[I&6ءq~Y??}/#ѰE5d!> /LH(!aDhI!1Z@Z!Sud%$&:"xOJIKh̚Z6M;G[ݭ=WR^m:QWys2n+|);Xt  E dNpVDi^PUK@ lVC-szc0рc206kLx*Yb߶o2ۑZb.ל3BZ:l~>|ȌCu=WfEb"~Ths>*ϪH;w 7l8~0{H"", |F c/yLٞ n|zں x/"zedx:{na5镖MH`JU;c,nXqf6ڜF Db5K x ~Hq(8FA- f>=::G3<*=  ܝ>xȽ?sh5XogRmJRej47_] OX83kUx^^ ]1es;D>Z2샕:ﱚn!H먓\C씫(52喳»}8;;򰨖m]&7Z*d0!08Ãt<:K L`PӬ(,).!Ip ?,E> endobj 68 0 obj <>stream BGIGNJ+AdvP7C31 %|b~ AdvP7C313bapqfdŒŠfq{_9-GR/ytx~Iީ -%GHGXXIfpa endstream endobj 60 0 obj <> endobj 69 0 obj <>stream h޴SSTe>aVSt?Lf7e$j! . h -,wv\$QpW .fh*/6Z6ceM5m}NYޙyyGBQdҸqkWό%<*j~T;5$\Rg&).k*kOI$}Xjgڙ2g":P Buܑhtu&2'YƮf1VMgna0vF3i Y#c4991tAkX :PZJR+7UTT 㮠[IK3R JRF=GqV7۫ͭՍVh6Xvv%Łt t |80B4 lY>X@_) g S6LCX㰶Y)ݱ-uO Wi nyt=Sz ,ǔ2Ĺ0 zsoyNB O/[dbSY^lKsYpo G*x\ $Kr&+PG'˄~Dz<{'wprz=d2B3}tej~l2iƄ@Vp2 ӄswr>~W+mx֐!l6WR Ut-`Q$q ݞ4Odo 1!1z{P/n \_?G7~_%MiCm r垒pN~ݽBO_.I--bJP>.kٱ+)77?8P,Y<'ySjGu{{C0:&jh۟N\Dc;+MF Y2+.};KtB;n::yCDsT 4^xTgd y/xx+XN%74i"220< W)S+n.FI׹Wߩ< u &rS&ii#޾r0DqVYmo+SU *WRvK $z܌YZnYYowg K+#r3]O4:)(@r?V)TW tUM$f(rn㦈|kA]}_ ϟzHdo c"Bo~ajϢI^:Ǒ)JSJ љJݎ@?LWCOym_LF.RͺJn9K/I<}h9yڳ;FNeš DOy@QM/ĐFc`[#nVB(XĽX{e2ak(̽ގܛrgh6#Цҷ`p_r;18[-R endstream endobj 61 0 obj <> endobj 70 0 obj <> endobj xref 0 71 0000000000 65535 f 0000001743 00000 n 0000000015 00000 n 0000000379 00000 n 0000000105 00000 n 0000001197 00000 n 0000002290 00000 n 0000001469 00000 n 0000000652 00000 n 0000000924 00000 n 0000002015 00000 n 0000002563 00000 n 0000006003 00000 n 0000006080 00000 n 0000006190 00000 n 0000006267 00000 n 0000006377 00000 n 0000006454 00000 n 0000006564 00000 n 0000045108 00000 n 0000006954 00000 n 0000048900 00000 n 0000046804 00000 n 0000047406 00000 n 0000043198 00000 n 0000006860 00000 n 0000023238 00000 n 0000023669 00000 n 0000042058 00000 n 0000055109 00000 n 0000043957 00000 n 0000023555 00000 n 0000036814 00000 n 0000041163 00000 n 0000041498 00000 n 0000041546 00000 n 0000042459 00000 n 0000045047 00000 n 0000045083 00000 n 0000045256 00000 n 0000045175 00000 n 0000049002 00000 n 0000050584 00000 n 0000051498 00000 n 0000052374 00000 n 0000053273 00000 n 0000054242 00000 n 0000056397 00000 n 0000057276 00000 n 0000045795 00000 n 0000046413 00000 n 0000049994 00000 n 0000050148 00000 n 0000045651 00000 n 0000069122 00000 n 0000071493 00000 n 0000048089 00000 n 0000048405 00000 n 0000057908 00000 n 0000060337 00000 n 0000072111 00000 n 0000073936 00000 n 0000056324 00000 n 0000056029 00000 n 0000055802 00000 n 0000055492 00000 n 0000066451 00000 n 0000069479 00000 n 0000071812 00000 n 0000072322 00000 n 0000074173 00000 n trailer <]/Info 70 0 R/Size 71>> startxref 74710 %%EOF